Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...